InternationalUSRemember you can easily switch between MIP US and MIP International at any time

European Commission claims pharma competition success

Legal Media Group


The proportion of problematic patent settlements in the pharmaceutical industry has fallen, even though the number of settlements has grown, according to the European Commission

In a statement published on January 31, the Commission said that its third annual survey had found that 11% of antitrust settlements were potentially problematic from an antitrust point of view, compared to 21% when the pharmaceutical sector enquiry was...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

New IP round-up from @mdloney, featuring biosimilars complaint, SiriusXM ruling, ED of Tex filing slump and more! https://t.co/1szaMeR3j1

Feb 23 2017 05:44 ·  reply ·  retweet ·  favourite
ManagingIP profile

Our analysis of SCOTUS Life Tech v Promega ruling https://t.co/CL6Ibt23RO Court didn't indicate how many components enough for infringement

Feb 23 2017 05:30 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @PatentScholar: SCOTUS opinion in LifeTech v. Promega is out—supply of single component doesn't lead to §271(f)(1) liability https://t.c

Feb 22 2017 04:57 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


February 2017

Top firms for trade marks 2017

Find out which firms are ranked in the first part of this year’s IP Stars research. Below, we provide a guide to the research and methodology



Most read articles

Supplements